Prescription Trends of Initial Pharmacotherapy for Benign Prostatic Hyperplasia Among Treatment-Naive Patients in South Korea: A Retrospective Analysis.

ABSTRACT:

Background

Benign prostatic hyperplasia (BPH) is a common urological condition in aging men that causes lower urinary tract symptoms. Pharmacotherapy is central to BPH management; however, considering updated guidelines, recent prescription trends remain insufficiently explored. This study aimed to assess initial pharmacotherapy trends in patients newly diagnosed with BPH.

Methods

This cross-sectional analysis used 2015-2020 data from the Health Insurance Review and Assessment Service to examine the trends and influencing factors of BPH drug utilization among South Korean patients aged ≥ 40 years with no prior history of BPH. Subgroup analyses were performed by categorizing patients into five age groups (40-49, 50-59, 60-69, 70-79, and ≥ 80 years) to evaluate age-specific pr

SUBMITTER: Kim YH 

PROVIDER: S-EPMC12411890 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature